1. Home
  2. BMRN vs DTM Comparison

BMRN vs DTM Comparison

Compare BMRN & DTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • DTM
  • Stock Information
  • Founded
  • BMRN 1996
  • DTM 2021
  • Country
  • BMRN United States
  • DTM United States
  • Employees
  • BMRN N/A
  • DTM N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • DTM Oil & Gas Production
  • Sector
  • BMRN Health Care
  • DTM Utilities
  • Exchange
  • BMRN Nasdaq
  • DTM Nasdaq
  • Market Cap
  • BMRN 11.1B
  • DTM 10.6B
  • IPO Year
  • BMRN 1999
  • DTM N/A
  • Fundamental
  • Price
  • BMRN $54.09
  • DTM $107.24
  • Analyst Decision
  • BMRN Buy
  • DTM Buy
  • Analyst Count
  • BMRN 24
  • DTM 12
  • Target Price
  • BMRN $91.70
  • DTM $109.17
  • AVG Volume (30 Days)
  • BMRN 1.8M
  • DTM 672.8K
  • Earning Date
  • BMRN 10-28-2025
  • DTM 10-28-2025
  • Dividend Yield
  • BMRN N/A
  • DTM 3.06%
  • EPS Growth
  • BMRN 154.69
  • DTM N/A
  • EPS
  • BMRN 3.40
  • DTM 3.74
  • Revenue
  • BMRN $3,063,608,000.00
  • DTM $1,109,000,000.00
  • Revenue This Year
  • BMRN $13.32
  • DTM $26.61
  • Revenue Next Year
  • BMRN $9.37
  • DTM $8.37
  • P/E Ratio
  • BMRN $15.91
  • DTM $28.69
  • Revenue Growth
  • BMRN 18.36
  • DTM 15.28
  • 52 Week Low
  • BMRN $52.93
  • DTM $74.46
  • 52 Week High
  • BMRN $85.00
  • DTM $114.50
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 37.63
  • DTM 64.17
  • Support Level
  • BMRN $55.99
  • DTM $102.43
  • Resistance Level
  • BMRN $59.79
  • DTM $107.67
  • Average True Range (ATR)
  • BMRN 1.57
  • DTM 2.01
  • MACD
  • BMRN -0.40
  • DTM 0.45
  • Stochastic Oscillator
  • BMRN 0.70
  • DTM 90.23

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About DTM DT Midstream Inc.

DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.

Share on Social Networks: